The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

16 Jun 2006 11:24

Deutsche Bank AG London16 June 2006 FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader Deutsche Bank AG London Company dealt in Cambridge Antibody Technology Group Plc Class of relevant security to which the Ordinarydealings being disclosed relate (Note 1) Date of dealing 15/06/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 10,798 £13.1116 £13.105 Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFDCFD Long 1,400 £13.1116CFD Long 9,398 £13.1088 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. Date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. NONE Date of disclosure 16/06/2006 Contact name Kelly-Jade Ledwich Telephone number 020 7545 7804 Name of offeree/offeror with which connected AstraZeneca PlcNature of connection (Note 6) Adviser to the offeror Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th May 201810:00 amRNSShare Interests Acquisition by CEO of Inv Manager
16th May 20187:00 amRNSNet Asset Value(s)
15th May 201812:35 pmRNSDirector/PDMR Shareholding
14th May 201812:51 pmRNSDirector/PDMR Shareholding
14th May 201812:02 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSPortfolio Update
19th Apr 20181:58 pmRNSResult of AGM
19th Apr 20187:00 amRNSNet Asset Value(s)
29th Mar 20187:00 amRNSNet Asset Value(s)
21st Mar 20183:52 pmRNSHolding(s) in Company
20th Mar 201812:45 pmRNSPublication of Suppl.Prospcts
12th Mar 20187:00 amRNSFinal Results
5th Mar 20187:00 amRNSNet Asset Value(s)
15th Feb 20184:00 pmRNSPublication of Suppl.Prospcts
14th Feb 20183:26 pmRNSHolding(s) in Company
12th Feb 20181:34 pmRNSHolding(s) in Company
9th Feb 201810:46 amRNSHolding(s) in Company
2nd Feb 20187:00 amRNSPortfolio Update
1st Feb 201812:00 pmRNSPublication of Suppl.Prospcts
31st Jan 20184:20 pmRNSDividend Declaration
19th Jan 20187:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Jan 20187:00 amRNSPRIIPs Key Information Documents
12th Dec 20177:00 amRNSNet Asset Value(s)
8th Dec 20177:00 amRNSIssue of Equity - correction
7th Dec 20175:44 pmRNSHolding(s) in Company
7th Dec 20177:00 amRNSIssue of Equity
5th Dec 20179:52 amRNSHolding(s) in Company
29th Nov 20174:40 pmRNSIssue of Equity - Correction
28th Nov 20173:50 pmRNSIssue of Equity
15th Nov 201711:02 amRNSPublication of Suppl.Prospcts
13th Nov 20177:00 amRNSNet Asset Value(s)
8th Nov 20177:00 amRNSPublication of a Prospectus
7th Nov 20171:17 pmRNSResult of Special General Meeting
6th Nov 20174:45 pmRNSHolding(s) in Company
17th Oct 20171:04 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSNet Asset Value
13th Oct 201711:36 amRNSNotice of GM
12th Oct 201712:44 pmRNSHolding(s) in Company
4th Oct 20172:00 pmRNSAGM Statement
2nd Oct 20177:00 amRNSIssue of Equity and Portfolio Update
21st Sep 20177:00 amRNSNet Asset Value(s)
29th Aug 201712:49 pmRNSStatement re Hurricane Harvey
18th Aug 20177:00 amRNSHalf-year Report
17th Aug 201711:54 amRNSHolding(s) in Company
17th Aug 20177:00 amRNSNet Asset Value(s)
20th Jul 20177:00 amRNSNet Asset Value(s)
21st Jun 20177:00 amRNSInvestment Manager - Executive Update
19th Jun 20177:00 amRNSNet Asset Value(s)
5th Jun 20173:20 pmRNSHolding(s) in Company
1st Jun 20176:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.